ArticleEuropean journal of clinical pharmacology2020

Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non-small cell lung cancer (NSCLC) with brain metastases.

Bharati Shriyan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.